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Bacterial pathogenesis involves social behavior
including biofilm formation and swarming, processes
that are regulated by the bacterially unique second
messenger cyclic di-GMP (c-di-GMP). Diguanylate
cyclases containing GGDEF and phosphodiester-
ases containing EAL domains have been identified
as the enzymes controlling cellular c-di-GMP levels,
yet less is known regarding signal transmission and
the targets of c-di-GMP. FimX, a protein from Pseu-
domonas aeruginosa that governs twitching motility,
belongs to a large subfamily containing both GGDEF
and EAL domains. Biochemical and structural anal-
yses reveals its function as a high-affinity receptor
for c-di-GMP. A model for full-length FimX was
generated combining solution scattering data and
crystal structures of the degenerate GGDEF and
EAL domains. Although FimX forms a dimer in solu-
tion via the N-terminal domains, a crystallographic
EAL domain dimer suggestsmodes for the regulation
of FimX by c-di-GMP binding. The results provide the
structural basis for c-di-GMP sensing via degenerate
phosphodiesterases.
INTRODUCTION
Bis-(30-50)-cyclic dimeric guanosine monophosphate (cyclic
di-GMP or c-di-GMP) emerged as a central second messenger
in eubacteria that controls community behavior, secretion, adhe-
sion, and motility, ultimately contributing to the virulence of path-
ogens (D’Argenio and Miller, 2004; Romling et al., 2005; Ross
et al., 1987). Diguanylate cyclases and phosphodiesterases
have been identified in large numbers in bacterial genomes,
and in GGDEF and EAL domains, respectively, and have been
shown to be responsible for the production and degradation of
c-di-GMP (Christen et al., 2005; Galperin et al., 2001; Hickman
et al., 2005; Paul et al., 2004; Ryjenkov et al., 2005; Schmidt
et al., 2005; Simm et al., 2004; Tal et al., 1998; Tamayo et al.,
2005). GGDEF and EAL represent conserved amino acid motifs
at the active site within the domains. These proteins cluster
into three classes that are often encoded in the same genome:
GGDEF domain-containing proteins, EAL domain-containing1104 Structure 17, 1104–1116, August 12, 2009 ª2009 Elsevier Ltdproteins, and proteins that contain a tandem GGDEF-EAL
domain. In many cases, the signature motif is degenerate and
the domains function as allosteric regulators of adjacent
domains (Christen et al., 2005; Newell et al., 2009). In the case
of GGDEF domains, a second c-di-GMP binding site is charac-
terized by an RxxD motif, called the inhibitory or I-site, and has
been shown to restrict the signaling potential of active diguany-
late cyclases via a negative feedback loop (Chan et al., 2004;
Christen et al., 2006; De et al., 2008; Wassmann et al., 2007).
Lagging behind the structural and functional characterization
of diguanylate cyclases and phosphodiesterases, the targets
and signaling mechanisms for c-di-GMP are largely unknown,
especially considering the high abundance and apparent
signaling specificity of cyclases and phosphodiesterases en-
coded in bacterial genomes (Beyhan et al., 2008; Kader et al.,
2006; Kulasakara et al., 2006; Sommerfeldt et al., 2009). In addi-
tion, it is believed that the majority of the cellular c-di-GMP pool,
typically 100–200 molecules per bacterial cell, is sequestered by
proteins, calling for receptors with high apparent affinity for the
nucleotide (Simm et al., 2009; Weinhouse et al., 1997). Yet, the
affinities reported for c-di-GMP receptors identified thus far
span multiple orders of magnitude, with many of the proteins
showing rather weak binding in vitro (Hengge, 2009).
Initial predictions, subsequently corroborated experimentally,
identified PilZ domains as c-di-GMP-binding modules (Amikam
and Galperin, 2006; Ryjenkov et al., 2006). Other studies
revealed FleQ and PelD from P. aeruginosa, proteins involved
in exopolysaccharide synthesis, as functional, PilZ-unrelated
c-di-GMP receptors (Hickman and Harwood, 2008; Lee et al.,
2007). Although both proteins affect the same pathway, they
are structurally unrelated. FleQ belongs to the AAA superfamily
and interacts with the alternative RNA polymerase sigma factor
S54 at enhancer sites to reciprocally regulate flagella biosyn-
thesis and secretion on a transcriptional level (Hickman and Har-
wood, 2008). In contrast, PelD is a transmembrane protein that
contains an RxxD motif that mimics the I-site found on GGDEF
domains (Lee et al., 2007). In addition, a prevalent riboswitch
class in messenger RNA of many bacteria possesses high affinity
for c-di-GMP and impacts gene expression (Sudarsan et al.,
2008), demonstrating the remarkable diversity in c-di-GMP
targets and signaling mechanisms.
In genome-wide studies of P. aeruginosa and E. coli, a fraction
of the GGDEF and/or EAL domain-containing proteins lacked
activity despite being expressed (Kulasakara et al., 2006; Som-
merfeldt et al., 2009). Although this could suggest that theseAll rights reserved
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Structure of the c-di-GMP Receptor FimXproteins might become active upon receiving a signal, many
display a degenerate diguanylate cyclase and phosphodies-
terase domain, and it has been proposed that inactive enzymes
could serve as c-di-GMP receptors. Such function has been
attributed to the GGDEF domain of PopA from Caulobacter cres-
centus and the EAL domain of the GGDEF-EAL domain-contain-
Figure 1. Structure of FimXEAL
(A) Domain organization of FimX. Protein constructs used in this study are indi-
cated. The sequence motifs of the putative inhibitory site (I-site), diguanylate
cyclase active site, and phosphodiesterase active site are shown.
(B) Crystal structure of apo-FimXEAL. The structure of the isolated EAL domain
of FimX from P. aeruginosa is shown as ribbon presentation in two orthogonal
views, with the molecular surface shown as inset. The EAL motif (E475VL in
FimX) is colored in yellow. The linker between the GGDEF and EAL domains
of FimX forms a helix in this structure and is colored in blue.Structure 17, 1104ing transmembrane protein LapD from P. fluorescence (Duerig
et al., 2009; Newell et al., 2009).
Here, we identify FimX (PA4959), a dual GGDEF-EAL domain-
containing protein involved in swarming behavior of P. aerugi-
nosa, as a high-affinity c-di-GMP receptor (Figure 1A) (Huang
et al., 2003). FimX regulates twitching motility and biofilm forma-
tion (Huang et al., 2003; Kazmierczak et al., 2006). Although
overexpression of FimX had no effect on pellicle formation and
cytotoxicity, transposon insertions and chromosomal deletions
at the FimX locus abolished biofilm formation (Huang et al.,
2003; Kulasakara et al., 2006). Although FimX was initially
described as an active phosphodiesterase (Kazmierczak et al.,
2006), degeneration of its EAL domain and lack of phosphodies-
terase activity has been predicted based on homology modeling
and was corroborated in enzyme assays (Rao et al., 2008), sug-
gesting an alternative mechanism for FimX function.
We present the crystal structure of the EAL domain of FimX in
its c-di-GMP-bound and apo-state, and in the context of the
GGDEF-EAL dual-domain module. In addition, we determined
the structure of the degenerate GGDEF domain, presenting
atomic models for the large family of degenerate GGDEF and
EAL domains. Although the GGDEF domain might not accom-
modate nucleotides, the EAL domain binds c-di-GMP with
high affinity in solution. Combining small-angle X-ray scat-
tering-based modeling with available crystal structures of the
isolated domains, a low-resolution envelope for dimeric full-
length FimX was derived. Based on the structural data, we
discuss potential molecular mechanisms that might explain
how c-di-GMP binding to the EAL domain of FimX could affect
biofilm formation.
RESULTS AND DISCUSSION
Crystal Structures of the EAL Domain of FimX
Studies described here were carried out with the full-length
protein (FimXfull-length) as well as four truncation constructs
comprising the N-terminal response receiver, PAS and GGDEF
domains (residues 1–431, FimXDEAL), the GGDEF-EAL dual-
domain module (residues 260–691, FimXdual), and the isolated
GGDEF and EAL domains (residues 260–431/FimXGGDEF and
429–691/FimXEAL, respectively) (Figure 1A). Proteins were over-
expressed in E. coli and purified to homogeneity using standard
affinity and size exclusion chromatography (see Experimental
Procedures for details). From all the protein constructs, FimXEAL,
FimXGGDEF, and FimXdual yielded suitable crystals for structure
determination (Table 1). The structure of FimXdual was solved
by single-wavelength anomalous dispersion phasing in the
space group P41212 with two molecules in the asymmetric
unit. The structure will be discussed later. FimXEAL crystallized
in both, the apo- and c-di-GMP-bound state in the space group
P6422 and P41212, respectively, and the structures were solved
at 2.3 A˚ and 1.5 A˚ resolution by molecular replacement using the
EAL domain model determined from crystals of FimXdual as the
search model.
The overall fold of the EAL domain of FimX is very similar to
that of the putative, EAL domain-containing phosphodiesterases
tdEAL from Thiobacillus dentrificans (PDB code 2r6o) and YkuI
from Bacillus subtilis (Protein Data Bank [PDB] code 2bas),
both determined recently by the Midwest Center for Structural–1116, August 12, 2009 ª2009 Elsevier Ltd All rights reserved 1105
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Structure of the c-di-GMP Receptor FimXTable 1. X-Ray Data Collection and Refinement Statistics
FimXEAL + c-di-GMP FimXEAL FimXdual FimXGGDEF
Data Collection
X-ray source CHESS, F1 NSLS, X29 CHESS, A1 CHESS, A1
Wavelength (A˚) 0.9180 1.0809 0.9771 0.9771
Space group P41212 P6422 P41212 P21
Unit cell parameters
a, b, c (A˚) 93.9, 93.9, 68.4 107.9, 107.9, 131.4 106.2, 106.2, 193.4 33.2, 94.1, 45.5
a, b, g () 90.0, 90.0, 90.0 90.0, 90.0, 120.0 90.0, 90.0, 90.0 90.0, 90.6, 90.0
Resolution range (A˚) 42.1  1.5 (1.56  1.5)a 46.7  2.3 (2.43  2.3) 48.9  3.0 (3.18  3.0) 47.0  2.0 (2.09  2.0)
No. of reflections
Total 696,341 (63645) 243,699 (38570) 317,432 (47627) 63,637 (6265)
Unique 54,448 (8121) 20,719 (3245) 42,159 (6702) 17,415 (2270)
Completeness (%) 98.4 (92.3) 99.8 (99.5) 99.5 (97.9) 93.6 (76.1)
Redundancy 12.8 (7.8) 11.8 (11.8) 7.5 (7.1) 3.6 (2.8)
I/s(I) 25.6 (3.5) 31.7 (5.2) 25.7 (4.4) 18.7 (6.4)
Rmeas (%) 5.3 (61.9) 6.2 (62.3) 6.2 (49.4) 5.8 (17.4)
Refinement
Rwork / Rfree (%) 19.1 / 21.2 19.5 / 23.7 20.2 / 25.2 21.3 / 24.6
Rmsd
Bond length (A˚) 0.007 0.008 0.010 0.003
Bond angles () 1.171 1.106 1.362 0.723
No. of atoms
Protein 1977 2059 3916 2666
Water 318 117 0 143
Average B-factors (A˚2)
Protein 32.2 51.1 89.8 26.3
Water 44.2 51.2 – 31.1
Ramachandran (%)b
Favored 94.6 93.6 85.7 92.8
Allowed 5.4 6.4 14.1 7.2
Generous 0.0 0.0 0.2 0.0
Disallowed 0.0 0.0 0.0 0.0
a Values for the highest-resolution bin.
b Calculated in PROCHECK (Laskowski et al., 1993).Genomics (unpublished; Minasov et al., 2009). Despite low
sequence identity (25% and 21% compared with tdEAL and
YkuI, respectively), the superimposed Ca atoms yield an rmsd
of 1.5 A˚ (over 215 Ca-positions) and 1.8 A˚ (over 194 Ca-posi-
tions), respectively. The EAL domain of FimX possesses 11
a helices and 8 b strands, and its fold resembles a TIM-like
barrel. However, in contrast to the classical (b/a)8 TIM barrel
fold, the succession of secondary structure elements in the
EAL domain barrel is ab(b/a)6b, where the first b strand is antipar-
allel with respect to the other 7 strands forming the barrel core
(Banner et al., 1975) (Figure 1B). In addition, the EAL domain of
FimX lacks two of the helices that surround the internal b strands
in canonical TIM barrels. An EAL domain-specific feature, a lobe
formed by two N-terminal helices (a0 and a1) and a helical inser-
tion between strand b2 and helix a3 in the TIM barrel (a2),
protrudes perpendicularly from the barrel plane (Figure 1B). Helix
a0 of the lobe in FimX is part of the linker region that connects the
GGDEF and EAL domains (Figure 1).1106 Structure 17, 1104–1116, August 12, 2009 ª2009 Elsevier LtdSoaking in a crystallization solution containing c-di-GMP dis-
solved the crystals of FimXEAL initially but the nucleotide-bound
protein recrystallized in an alternative space group (see above;
Table 1). Similar to several other TIM-barrel-containing enzymes
and the EAL domain of YkuI (Hocker et al., 2001; Minasov et al.,
2009), the c-di-GMP binding site of FimXEAL, including the degen-
erate EAL motif (E475VL in FimX), is located at the C-terminal end
of the b strands composing the barrel, and a c-di-GMP molecule
was modeled with high confidence into the density at that site
(Figures 1B and 2A). Unlike the stacked c-di-GMP dimers bound
at the active site and I-site of GGDEF domains (Chan et al., 2004;
De et al., 2008), the nucleotide bound to FimXEAL assumed an
extended conformation that is perpendicular to the axis defined
by the strands of the TIM barrel (Figure 2A), and similar to the
conformation observed in the structure of the EAL domain from
YkuI (Figure 2B) (Minasov et al., 2009).
Cyclic di-GMP binding had very little impact on the conforma-
tion of the TIM barrel, exemplified by an overall rmsd of 0.32 A˚All rights reserved
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Structure of the c-di-GMP Receptor FimX(over all atoms) between the two structures. The most notable
difference was a bilateral clamping down of the protein onto
the c-di-GMP molecule. While this involved aromatic p-stacking
Figure 2. Structural Comparison between the c-di-GMP-Bound
Form and the Apo-State
(A) Crystal structure of FimXEALdc-di-GMP. The c-di-GMP-bound structure of
FimXEAL, (colored in gray) was superimposed onto the nucleotide-free struc-
ture (colored in red) shown in Figure 1. Although present in the construct,
the linker helix (blue) is disordered in FimXEALdc-di-GMP. The bottom panel
shows a close-up view of the nucleotide binding pocket, with residues
involved in c-di-GMP binding shown as sticks. The (jFoj-jFcj) electron density
map is shown as calculated from a model prior to inclusion of nucleotide and is
contoured at 3s.
(B) Comparison of the degenerate EAL domain of FimX and the EAL domain of
YkuI. The c-di-GMP-bound state of FimXEAL (gray) and YkuIEAL (PDB code
2w27; cyan) were superimposed. Nucleotide and magnesium coordinating
residues are shown as sticks. Residue type and sequence position are indi-
cated (left: FimXEAL, right: YkuIEAL). YkuI was crystallized in the presence of
calcium (green sphere).Structure 17, 1104interactions between one guanosine base and Y673, adopting an
alternative rotamer conformation compared with the apo-state,
and F652 of FimX on one side, the second guanosine base of
the nucleotide occupied a somewhat hydrophobic cavity formed
at the interface of the lobe (helix a2) and the barrel core
(Figure 2A). Interactions of helix a2 with the second guanosine
base of c-di-GMP induce a rigid body shift of the lobe by
3.7 A˚, concomitant with a melting of the linker helix a0 (Figure 2A,
top panel).
Several highly conserved residues in EAL domains have been
identified based on homology modeling, and were shown to be
essential for phosphodiesterase activity (Rao et al., 2008). Struc-
tural characterization of the c-di-GMP-bound EAL domain of
YkuI corroborated these findings (Minasov et al., 2009). Resi-
dues crucial for activity included a conserved general base cata-
lyst (E352 in RocR/SadR, E239 in tdEAL/2R60, or E209 in YkuI) and
the Mg2+-coordinating residues N88, E122, D152, and E523, the
glutamic acid residue from the EAL motif (YkuI numbering). In
FimX, the general base-catalyst is substituted by a proline
(P651). In addition, three of the Mg2+-coordinating side chains
have been replaced nonconservatively in FimX (H533, Q565, and
S595 corresponding to N88, E122, and D152 of YkuI, respectively)
(Figure 2B). Indeed, no metal ion could be identified in the
respective binding site of FimX. However, several other residues
that potentially play an important role in c-di-GMP binding (Min-
asov et al., 2009; Rao et al., 2008), such as Y231, E212, D65, R37,
and L35 of YkuI, are conserved in FimX and mediate numerous
specific polar and hydrophobic interactions between the protein
and the nucleotide (Y673, E654, D507, R479, and L477 in FimX;
Figure 2B). One of the phosphates of c-di-GMP participates in
a charge-charge interaction with the conserved R479, whereas
residue L477 of the EVL motif serves as a platform to support
the phosphate ring of the cyclic nucleotide.
We determined the affinity and stoichiometry of c-di-GMP
binding by using isothermal titration calorimetry. The isolated
EAL domain of FimX bound c-di-GMP with high affinity (Kd =
104.2 nM) and stoichiometry of 1:1.11 (Figure 3A). A similar
affinity and stoichiometry (Kd = 125.0 nM; N = 0.93) were found
for full-length FimX (Figure 3B). The titration with FimXfull-length
showed an initial slope that might indicate a cooperative or
sequential binding of c-di-GMP, and fits using such models
were marginally better. Because the molecular basis for such a
phenomenon is currently unknown, we report values for a simple
one-site binding model. The affinity of FimX for c-di-GMP was at
the higher end of the spectrum reported for other EAL domains
and c-di-GMP receptor proteins, which spans three orders of
magnitude (60 nM to low micromolar) (Hengge, 2009).
Taken together, the structural analysis revealed the molecular
basis for c-di-GMP binding to a degenerate EAL domain. The
results suggest that FimX functions as a high-affinity c-di-
GMP-binding protein that lacks enzymatic activity, consistent
with previous studies and our biochemical characterization (Ku-
lasakara et al., 2006; Rao et al., 2008) (see Figure S1 available
online).
Structure of the Degenerate GGDEF Domain of FimX
Crystals of FimXGGDEF diffracted X-rays to 2.0 A˚ resolution, and
the structure was solved by molecular replacement in space
group P21 with the GGDEF domain of PleD as the search model–1116, August 12, 2009 ª2009 Elsevier Ltd All rights reserved 1107
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Structure of the c-di-GMP Receptor FimXFigure 3. Isothermal Titration Calorimetry Data for c-di-GMP Binding to FimX
(A) Binding of c-di-GMP to FimXEAL. Calorimetric titration for c-di-GMP (250 mM) titrated into FimXEAL (25 mM) is shown. Derived values for Kd and stoichiometry (N)
are shown.
(B) Binding of c-di-GMP to full-length FimX. Calorimetric titration for c-di-GMP (250 mM) titrated into full-length FimX (25 mM) is shown. Derived values for Kd and
stoichiometry (N) are shown.(PDB code 1w25; Chan et al., 2004). The asymmetric unit con-
tained two GGDEF domain molecules. Although GGDEF domain
dimerization plays an important role in the catalytic activity and
regulation of active cyclases (Chan et al., 2004; De et al., 2008;
Wassmann et al., 2007), packing contacts in FimXGGDEF crystals
differ from the ones observed previously and are likely to be bio-
logically irrelevant, considering the small dimensions of interfa-
cial areas (614 A˚2 which corresponds to 7.5% of the total GGDEF
domain surface) (Krissinel and Henrick, 2007).
Similar to the GGDEF domains of PleD and WspR, the overall
fold of the FimX diguanylate cyclase domain consists of a central
five-stranded b sheet surrounded by five a helices (Figure 4A)
(Chan et al., 2004; De et al., 2008). With the exception of some
flexible loops, the GGDEF domain of FimX superimposed very
well on the cyclase domains from PleD (root-mean-square devi-
ation [rmsd] of 1.2 A˚ for 150 Ca) and WspR (rmsd of 1.3 A˚ for
152 Ca). The characteristic GGEEF motif (G
346DSIF in FimX)
formed a loop between b2 and b3. However, several residues
important for catalysis and nucleotide binding underwent
nonconservative changes in FimX, yielding a degenerate GGDEF
domain that is inactive (Figure S1). The GGDEF domain of FimX
lacks residues that coordinate the g-phosphate moiety of GTP
(K442 and R446 in PleD, substituted by A418 and G422 in FimX),
as well as residues involved in Mg2+ coordination (E370 of the
GGEEF motif and D327 in PleD, substituted by S348 and H305 in
FimX; closed arrows in Figure 4D; Figure 4B) (Wassmann et al.,
2007). Some of the residues that contribute to a binding pocket
for the guanosine base, in particular D322 and Y309, are
conserved or similar to active cyclases, suggesting that FimX1108 Structure 17, 1104–1116, August 12, 2009 ª2009 Elsevier Ltdmight still be able to bind GTP (asterisks in Figure 4D). In the
conformation observed in the crystals, D347 of the GDSIF motif
and Y309 occupy the nucleotide binding cleft, and GTP binding
would require a remodeling of this site. CC3396 from Caulo-
bacter crescentus, a dual-domain phosphodiesterase that
becomes activated allosterically by GTP binding to its degen-
erate GGDEF domain, contains a glutamate substitution instead
of the second glycine at its signature motif (GEDEF), but unlike
FimX displays residues that can interact with the phosphate
moieties of GTP (open arrow in Figure 4D) (Christen et al.,
2005). Considering the already rather low affinity of CC3396 for
GTP (4 mM), nucleotide binding to the GGDEF domain of
FimX is likely to be even weaker, consistent with a lack of GTP
binding in vitro (data not shown).
Superimposing the nucleotide-free GGDEF domain of FimX
with that of c-di-GMP-bound PleD revealed the incompatibility
of product binding to FimX at the active site. FimX lacks side
chains important for c-di-GMP binding, and D347 of the GDSIF
motif, located at the position of the second conserved glycine
residue in active GGDEF domains, introduced a major steric
clash with the nucleotide (Figure 4C, left panel) (Chan et al.,
2004). In addition to the GGDEF and EAL domain active sites,
a third c-di-GMP binding site has been identified in diguanylate
cyclase structures, and has been shown to function as an inhib-
itory site (I-site) (Chan et al., 2004; Christen et al., 2006; De et al.,
2008; Wassmann et al., 2007). The I-site plays an important role
in the regulation of cyclase activity and its architecture is distinct
compared with the active site. It is formed by a characteristic
primary site motif with the consensus RxxD (R359xxD andAll rights reserved
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Structure of the c-di-GMP Receptor FimXFigure 4. Structure of the Degenerate GGDEF Domain of FimX
(A) Crystal structure of FimXGGDEF. The GGDEF domain of FimX is shown in
green. The degenerate GGDEF motif (G346DSIF in FimX) at the active site is
colored in orange. The right panel shows a superposition with the GGDEF
domain of the active diguanylate cyclase PleD from Caulobacter crescentus
(PDB code 1w25; gray).
(B) Close-up view of the degenerate nucleotide binding site of FimXGGDEF. The
structures of nucleotide-free FimXGGDEF (green) and the GGDEF domain of
PleD bound to a nonhydrolyzable GTP analog (PDB code 2v0n; gray) were
superimposed. The degenerate GDSIF motif of FimX is colored in orange.
Nucleotide and magnesium (yellow sphere) coordinating residues are shownStructure 17, 1104R242xxD in PleD and WspR, respectively). From sequence and
structural alignments, the GGDEF domain of FimX lacks this
motif, ruling out c-di-GMP binding via an I-site (Figure 4C, right
panel; Figure 4D). Nucleotide binding studies in solution
confirmed the EAL domain as sole c-di-GMP binding module
of FimX (Figure S2).
EAL Domain Dimerization in the Structure of FimXdual
Next, we determined the crystal structure of FimXdual. Although
the protein contained both the GGDEF and EAL domains
(residues 260–691 of FimX), density for the first 177 N-terminal
residues covering the entire GGDEF domain was absent after
refinement of the EAL domain. Disordered domains have been
reported before in crystal structures such as in the case of
some flavoproteins (Gruez et al., 2000; Leys et al., 2003). To
rule out the possibility of limited protein degradation during crys-
tallization, crystals were washed and analyzed by SDS-PAGE.
The silver-stained gels showed a single band corresponding to
the intact dual-domain protein that was used as the input mate-
rial (Figure S3A). Inspection of the crystal lattice revealed large
cavities that could accommodate the GGDEF domain from
both molecules of FimXdual in the asymmetric unit (Figure S3B).
Furthermore, the crystal solvent content (VM) estimated based
on the protein molecular weight and crystal lattice dimensions
indicated the dual-domain module as protomer rather than
the final structural model, which comprised only the EAL
domains (residues 437–687), considering average solvent
contents observed for protein crystals (VM
dual = 58.5% versus
VM
final model = 74.8%). Given the relatively low Rfree of 25.2% of
the refined model at a resolution of 3.0 A˚, the GGDEF domain
is presumably disordered in the crystals with insignificant
contribution to the diffraction of X-rays.
The EAL domain of FimXdual crystallized in a dimeric state that
was formed by the two molecules in the asymmetric unit. In such
an assembly, the lobes of the protomers engage in mutual inter-
actions with the TIM barrels of the adjacent chains (Figure 5A).
Helix a0 melted and part of the loop structure contributes to
dimerization. Although pair-wise contacts in the interface involve
mainly backbone atoms and lack ionic bonds, there is a remark-
able shape and physicochemical complementarity across
3300 A˚2 of buried surface area (Figure 5A). Computational anal-
ysis of the protein interface suggested that the interface is of
biological relevance with an estimated solvation free energy
(DiG) of 11.9 kcal/mol, according to the PISA server (Krissinel
and Henrick, 2007).
as sticks. Residue type and sequence position are indicated (left: FimXGGDEF,
right: PleD).
(C) Cyclic di-GMP-incompatible active and I-sites of FimXGGDEF. The struc-
tures of nucleotide-free FimXGGDEF (green) and the GGDEF domain of PleD
bound to c-di-GMP at the active (left panel) and I-site (right panel) (PDB
code 2w25; gray) were superimposed. Cyclic di-GMP coordinating residues
of PleD and corresponding residues of FimX are shown as sticks.
(D) Sequence alignment of nucleotide binding motifs in GGDEF domain-
containing proteins. GGDEF domain sequences from FimX, WspR, PleD,
and CC3396 were aligned using ClustalW. Sequence blocks spanning the
nucleotide binding sites (colored residues) are shown. Residues involved in
magnesium binding (filled arrows) and GTP binding (open arrow and asterisks)
are highlighted. The GGDEF motif and the I-site are colored in green and red,
respectively.–1116, August 12, 2009 ª2009 Elsevier Ltd All rights reserved 1109
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Structure of the c-di-GMP Receptor FimXThe EAL domain dimer forms a cage burying the nucleotide
binding sites in an inner cavity inaccessible for nucleotide binding
(Figure 5A). In addition, placing a c-di-GMP molecule into the
binding site based on a structural alignment with FimXEALdc-di-
GMP revealed that the conformation of FimX in the dimer is
Figure 5. Structure of an EAL Domain Dimer
Observed in FimXdual Crystals
(A) Crystal structure of a homodimeric EAL domain of
FimX. In the structure of FimXdual, the two EAL domains
in the asymmetric unit (colored in red and gray) form a
dimeric assembly. The inset (top left panel) shows a
surface presentation of an EAL domain monomer. The
nucleotide binding site is colored in blue. Two orthogonal
views are shown. The N termini of the EAL domain are
colored in green.
(B) Blocked c-di-GMP binding in the dimer. The structures
of FimXEALdc-di-GMP and FimXdual were superimposed.
Only the nucleotide of the c-di-GMP-bound structure is
shown as sticks. The close-up view (right panel) shows
clashes of c-di-GMP with the dimeric EAL domain.
incompatible with c-di-GMP binding (Figure 5B).
Major clashes between the nucleotide and the
protein involved the backbone of helix a2 of the
dimerization partner and the side chain of E492
in that helix (Figure 5B, right panel). By accom-
modating helix a2 of an adjacent protomer, the
side chain of Y673, one of the two residues that
clamps the guanosine base via aromatic stack-
ing interactions, faces away from the nucleo-
tide-binding site (Figure 5B, right panel). We
predict that nucleotide binding would disrupt
such dimer conformation.
Interestingly, apo-FimXEAL formed a similar
dimer in the crystal lattice with a symmetry-
related molecule (Figure 6A). Despite the different construct
boundaries and crystallographic space groups (P41212 for
FimXdual and P6422 for FimX
EAL), the relative domain orientation
and core interfacial surfaces in both dimers were comparable
(Figure 6). Although the interactions between the lobes of
Figure 6. Dimer Interfaces in EAL Domain-
Containing Structures of FimX
(A) Conformational variation in FimXEAL and
FimXdual domain dimers. A comparison of the
EAL domain dimer observed in the crystal struc-
ture of FimXdual (left panel) and the FimX dimer in
apo-FimXEAL (middle panel) crystals is shown.
The structure of FimXdual is colored as in Figure 4.
The protomers of the FimXEAL structure are
colored in yellow and dark gray, with their N termini
shown as orange spheres. The right panel shows
a superposition of the two dimers using a single
EAL domain as reference. The inset is an orthog-
onal view highlighting the position of the N termini
in both dimers.
(B) Mapping of dimer interfaces onto the surface of
the EAL domain. The structure of FimXEAL shown
as ribbons (left panel) depicts the orientation of
the surface presentations (middle and right panel).
In the middle panel, interfacial residues of the apo-
FimXEAL dimer are colored orange. Additional resi-
dues contributing to dimerization in FimXdual are
colored in red. In the right panel, a dimer interface
observed in structures of the EAL domain-contain-
ing protein tdEAL and YkuI is colored in cyan on
the surface of the crystal structure of YkuI (PDB
code 2w27).1110 Structure 17, 1104–1116, August 12, 2009 ª2009 Elsevier Ltd All rights reserved
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concomitant c-di-GMP binding, the cage formed by dimerization
was less closed than that observed in the crystals grown with
FimXdual. Differences originated from a rigid body rotation of
one EAL domain by 11 with respect to the adjacent EAL
domain, which resulted in a reduction in buried surface area of
1000 A˚2 (Figure 6). While the N-terminal linker participates in
dimerization of FimXdual placing the N-termini at the center of
the assembly, this motif forms helix a0 in apo-FimXEAL. The
engagement of the helix in the dimer interface is less extensive
and the N-termini are more separated in this alternative dimer
conformation, pointing away from the core (Figure 6A, right
panel). Energetic estimations predicted that the weaker interface
retained its biological relevance, suggesting that structural
changes in the linker helix a0 that connects the GGDEF and
EAL domains could be functionally coupled to the opening of
the dimer interface or vice versa.
The potential biological significance of the dimer interface pre-
sented here is unclear. As we describe below, the EAL domain is
monomeric in solution and unlikely to form this interaction in the
context of the full-length FimX dimer conformation observed in
solution. However, it is tempting to speculate that similar interac-
Figure 7. Oligomerization State of FimX in Solution
(A) Size exclusion chromatography. Standard proteins (arrows), FimX full-
length and truncations were analyzed by size exclusion chromatography in
gel filtration buffer. Standardization using elution times, molecular weights of
the standard proteins, and column specifics yielded a standard curve for
molecular weight estimations for FimX.
(B) Analytical ultracentrifugation. FimX full-length and truncations were
analyzed by sedimentation velocity analytical ultracentrifugation in gel filtration
buffer. Molecular weights were analyzed by using the program SedFit.Structure 17, 1104tions could mediate higher-order oligomerization or complex
formation with other proteins (see discussion below).
Mapping of sequence conservation considering all 16
GGDEF-EAL domain-containing proteins from P. aeruginosa
onto the accessible surface of FimXEAL indicated that this dimer
interface might not be a general feature in EAL domains
(Figure S4). In addition, dimerization of the EAL domains of
FimX was not observed in solutions of purified proteins (see
below). The interface is distinct from and nonoverlapping with
those observed in structures of tdEAL and YkuI, two unrelated,
presumably active EAL domains (Figure 6B) (Minasov et al.,
2009). Despite low overall sequence similarity, both tdEAL and
YkuI use a common, conserved interface for dimerization
located on the TIM barrel distal to the active site and the lobe.
Although the interface is moderately conserved in FimX, dimer-
ization via this surface is prohibited due to backbone clashes
in the current conformation of the FimX EAL domain (data not
shown). Interestingly, this dimerization motif that corresponds
to a loop region in the EAL domain has recently been identified
as being functionally linked to catalysis in active phosphodies-
terases (Rao et al., 2009).
Structural Characterization of FimX in Solution
In size exclusion chromatography, full-length FimX and the trun-
cated forms eluted in single sharp peaks, indicating that the
proteins were monodispersed with regard to their oligomeric
state in solution (Figure 7A). Calibration using globular standard
proteins indicated that FimXdual and constructs that contained
the N-terminal response receiver and PAS domains, FimXDEAL
and FimXfull-length, eluted at volumes more consistent with higher
molecular weight forms than predicted from the protein
sequence, or with proteins of nonglobular shape, while FimXEAL
appeared monomeric in solution (Figure 7A; Table 2).
The accurate molecular weight and oligomeric state of FimX
was elucidated by sedimentation velocity analytical ultracentrifu-
gation (Figure 7B). Based on their sedimentation coefficients and
frictional ratios, FimXEAL and FimXdual were monomeric (Table 2).
The larger frictional ratio for FimXdual (and the elution volume in
gel filtration experiments) indicated that the protein is in an
extended conformation. For FimXDEAL and FimXfull-length, the
sedimentation coefficients and frictional ratios described
dimeric proteins with nonglobular shape in solution, which
explained the higher apparent molecular masses estimated
from size exclusion chromatography data (Table 2). These
Table 2. Molecular Weight of FimX in Solution
Molecular Mass (kDa) Sedimentation
Coefficient (S)
Frictional
RatioSequencea SECb SAXSc AUCd
FimXfull-length 76.0 308.0 137.6 141.4 5.69 1.63
FimXDEAL 47.4 155.0 101.1 97.7 4.65 1.67
FimXdual 47.3 61.6 44.4 43.3 2.96 1.50
FimXEAL 28.9 28.2 26.2 26.2 2.38 1.31
a Molecular mass calculated from the primary sequence.
b Molecular mass calculated from size exclusion chromatography.
c Molecular mass calculated from small-angle X-ray scattering data (see
Table S1).
d Molecular mass calculated from sedimentation velocity analytical ultra-
centrifugation.–1116, August 12, 2009 ª2009 Elsevier Ltd All rights reserved 1111
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Structure of the c-di-GMP Receptor FimXresults elucidated that FimX is an elongated protein in solution,
which dimerizes through its N-terminal domains.
To determine the overall architecture and solution conforma-
tion of FimX and its nucleotide-bound states, we turned to
small-angle X-ray scattering. This method yields molecular
geometry parameters such as the radius of gyration (Rg) and
maximum diameter of a molecule or assembly (Dmax), as well as
Figure 8. Solution Scattering Analysis of
FimX
Small-angle X-ray scattering curves and distance
distribution functions of FimXfull-length (A), FimXDEAL
(B), FimXdual (C), and FimXEAL (D) are shown after
averaging and subtraction of solvent background
scattering. Theoretical scattering profiles calcu-
lated from the ab initio models with the lowest c
values are shown (black line; see Figure 9). The
inset shows Guinier plots (including linear fits) at
the low angle region (Smax*Rg < 1.3). For
constructs containing the EAL domain, experi-
ments were also performed in the presence of
c-di-GMP (dashed gray lines).
the distance distribution or P(r) function,
describing the shape of a molecule in
solution. We collected and analyzed
data for FimXfull-length, FimXDEAL, FimXdual
and FimXEAL, and for the c-di-GMP-
bound states of the EAL domain-contain-
ing constructs (Figure 8; Table S1). The
apo-FimXEAL and its c-di-GMP-bound
state showed very similar dimensions
and shapes that were in agreement with
the parameters calculated from the crys-
tal structures (Figure 8D; Table S1). Simi-
larly, Rg, Dmax, and P(r) functions deter-
mined for FimXfull-length and FimXdual
were insensitive to c-di-GMP binding,
ruling out major conformational rear-
rangements upon nucleotide binding
(Figures 8A and 8C; Table S1). The P(r)
functions calculated for the full-length
protein showed two main peaks and
a shoulder at larger distances, character-
istic of an elongated conformation com-
prising multiple folded domains. The P(r)
function for FimXDEAL revealed a similar
pattern with two main peaks but a smaller
shoulder and overall shorter Dmax
(Figure 8B). The analysis of the solution
scattering data suggested that the EAL
domains are located at the distal tips
of the elongated dimer, contributing to
a larger diameter of the full-length
assembly.
Modeling of the SAXS data provided
low-resolution envelopes corroborating
the results described above. Positions
of spherical scattering units representing
residues in a protein were adjusted by
a simulated annealing procedure to optimally match the scat-
tering data (Svergun et al., 2001). FimXfull-length and FimXDEAL
were shown previously to be dimeric in solution by analytical
ultracentrifugation, and two-fold symmetry was imposed during
the modeling of these proteins (trials in the absence of symmetry
yielded comparable results; data not shown). For each protein, at
least 20 independent simulated annealing runs were carried out,1112 Structure 17, 1104–1116, August 12, 2009 ª2009 Elsevier Ltd All rights reserved
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of fit to the experimental scattering data (Svergun, 1999). Super-
position, averaging over all models, and filtering of the most
reproducibly modeled regions generated a consensus or filtered
envelope (Figure 9, colored envelopes) (Volkov and Svergun,
2003). The envelopes colored in gray represent the sum of all
models prior to filtering.
As expected from the Gaussian-shaped P(r) function, models
for the isolated EAL domain of FimX described a globular domain
into which the crystal structure could be docked (Figure 9A,
bottom panel). A short extension observed in the solution enve-
lopes accommodated the lobe of the EAL domain, highlighting
the quality and information content of the ab initio modeling.
Models for FimXdual described a monomeric, bean-shaped
module, and the high-resolution structures of the isolated EAL
and GGDEF domains could be placed into the envelope with
high confidence (Figure 9A). The refined envelope covering
both domains is in contrast to the lack of density for the GGDEF
domain in FimXdual crystals, and suggests that the GGDEF
domains were not coordinated by crystal packing contacts and
might undergo conformational sampling as rigid bodies.
Envelopes calculated for FimXDEAL were consistent with an
elongated assembly containing a central dimerization hub (Fig-
Figure 9. SAXS-Based Shape Reconstruc-
tion of FimX
(A) SAXS-based shape reconstruction of FimXEAL
(red), FimXdual (green), FimXDEAL (blue), and
FimXfull-length (orange) are shown after averaging
of 20 independent models (gray envelopes) and
filtering (colored enveloped). High-resolution
crystal structures of the EAL and GGDEF domains
were docked into the appropriate envelopes and
are shown in cartoon presentation.
(B) Model for full-length FimX. High-resolution
crystal structures of the EAL and GGDEF domains,
as well as models for the dimeric response
receiver and PAS domains (PDB codes 3BRE
and 1DRM, respectively; De et al., 2008; Gong
et al., 1998) were docked into the envelopes
modeled from the solution scattering of full-length
FimX, and are shown in cartoon presentation. A
superposition of solution envelopes for FimXDEAL
(blue) and FimXfull-length (orange) is shown. The
circle highlights a region in the FimXfull-length enve-
lope that is missing in the FimXDEAL envelope.
ure 9A). Models of dimeric FimXfull-length
had a similar serpentine shape but were
extended in the longest dimension (Fig-
ure 9A). Superposition of the FimXDEAL
and full-length envelopes allowed us to
map the position of EAL domains in the
context of the entire protein (Figure 9B).
EAL domains were located at the far
ends of the protein, separated by the
N-terminal and GGDEF domains. Given
the domain organization, the response
receiver domains are likely to mediate
dimerization while the GGDEF domains
form the protrusions observed in the
FimXDEAL models. Manual docking of crystal structures and the
tendency of response receiver domains to dimerize support
such a model (Figure 9B).
Taken together, the solution scattering-based analysis
revealed an extended conformation of full-length FimX, in which
the N-terminal domains separate the EAL domains. In this
conformation, the EAL domains are unpaired, in contrast to the
dimeric assemblies observed in the crystal structures of apo-
FimXEAL and FimXdual. The monomeric state of the EAL domains
in solution suggests that dimerization via this interface is kineti-
cally unfavorable, in agreement with the lack of long-range elec-
trostatic interactions (Elcock et al., 1999).
Putative Models for FimX Function
in c-di-GMP Signaling
Functional studies elucidated a role for FimX in twitching motility
with the phenotypes of gene disruptions suggesting that FimX
resembles either a c-di-GMP receptor or negative regulator of
phosphodiesterases, rather than an active phosphodiesterase
(Huang et al., 2003; Kulasakara et al., 2006). Interestingly, proper
localization of FimX to a single pole in cells relies on intact
G346DSIF and E475VL motifs in FimX, suggesting that both the
degenerate GGDEF and EAL domains are important forStructure 17, 1104–1116, August 12, 2009 ª2009 Elsevier Ltd All rights reserved 1113
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Structure of the c-di-GMP Receptor FimXmolecular interactions (Kazmierczak et al., 2006). Our structural
and biochemical analyses revealed that the EAL domain of FimX
is still capable of c-di-GMP binding but lacks important residues
for catalysis, consistent with previous reports (Kulasakara et al.,
2006; Rao et al., 2008). Two of the EAL domain-containing
crystal structures showed an extensive dimerization interface
that is incompatible with c-di-GMP binding. In contrast, solution
scattering-based shape reconstructions indicated monomeric
EAL domains in the context of full-length FimX, which forms
a dimer via its N-terminal domains.
Integrating our data and previous studies, two plausible
molecular mechanisms for the cellular function of FimX can be
proposed. In a canonical receptor model for FimX function,
c-di-GMP would bind to the EAL domain with high-affinity.
Complex formation with yet unidentified binding partners might
be regulated by c-di-GMP binding to the EAL domain. Complex
formation could be facilitated by c-di-GMP binding to FimX
(as shown in Figure S5A), but it is equally feasible that the mono-
meric, nucleotide-free EAL domain is engaged in interactions
that become destabilized upon nucleotide binding. Interestingly,
the degenerate EAL domain of a blue light sensor from E. coli has
recently been identified as a module for controlled protein inter-
actions (Tschowri et al., 2009). Binding and release of the partner
protein is regulated by the light-sensing domain located adjacent
to the EAL domain, but is independent of c-di-GMP degradation
or binding. In another recent case, a catalytically inactive
GGDEF-EAL domain-containing protein has been shown to
transmit signals across the cell membrane via c-di-GMP binding
to its degenerate EAL domain (Newell et al., 2009). The two
studies reveal the usage of EAL domains as switchable protein
or nucleotide binding modules, and FimX might combine both
features in controlling swarming behavior.
An extension of this model could involve c-di-GMP-triggered
dissociation of FimX EAL domain dimers (Figure S5A). Disrupting
EAL domain dimers or oligomers might already provide a switch,
either in conformation or localization. Although we cannot
exclude conformational changes within the full-length protein
that would bring the EAL domains into close proximity for dimer-
ization, an alternative model could involve the formation of
higher-order oligomers at regions of high local protein concen-
tration such as the pole of the bacterial cell, where FimX accumu-
lates (Huang et al., 2003; Kazmierczak et al., 2006).
In an alternative model, other EAL or dual GGDEF-EAL domain-
containing proteins could form specific complexes with FimX via
interactions similar to the ones observed in FimX EAL domain
homodimers. Such assemblies would sequester the active site of
the partner EAL domain (and possibly the GGDEF domain in the
caseof dual domainproteins), rendering them unavailable forcatal-
ysis (Figure S5B). The FimXEAL and FimXdual dimerization is in part
facilitated by shape complementarity and backbone interactions,
which are likely to be conserved features in EAL domains. This
model would predict that c-di-GMP binding to the EAL domain of
FimXwould liberate thepartnerEALdomain, revealing itsphospho-
diesterase active site. Such a mechanism would be also consistent
with the mutational studies (Kulasakara et al., 2006). An attractive
feature of the phosphodiesterase inhibitor model is the prediction
that the activation of partner EAL domains would be self-limiting
because the freed activity would eventually degrade the c-di-
GMP molecule that is bound to FimX, reversing the process.1114 Structure 17, 1104–1116, August 12, 2009 ª2009 Elsevier LtdDegenerate domains with alternative functionality might
account in part for the large number of GGDEF and EAL domains
encoded in eubacterial genomes and for the complexitity in
c-di-GMP-mediated signaling. Little is known about the binding
partners of GGDEF and EAL domain-containing proteins and the
targets of c-di-GMP, and how the signal is transmitted. Genetic
and phenotypic analyses provided invaluable information
regarding proteins that affect similar pathways and clearly
demonstrated signaling specificity and hierarchy (Beyhan
et al., 2008; Kader et al., 2006; Kulasakara et al., 2006; Sommer-
feldt et al., 2009). Deciphering the interactions of FimX and other
factors involved in c-di-GMP signaling on a molecular level will
be instrumental in determining the mechanism underlying FimX
function, and signal transmission in general.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
The coding region corresponding to full-length FimX from P. aeruginosa PAO1
(Huang et al., 2003) was amplified by standard polymerase chain reaction
(PCR) using genomic DNA as a template. Coding regions corresponding to
FimXDEAL (residues 1–431), FimXdual (residues 260–691), FimXEAL (residues
429–691), and FimXGGDEF (residues 260–431) were PCR amplified from an
expression plasmid encoding FimXfull-length. DNA inserts were cloned into
a modified pProExHTb (Invitrogen) expression plasmid yielding N-terminally
hexahistidine-tagged proteins (FimXfull-length, FimXdual, and FimXGGDEF), or
into a modified pET28a expression plasmid (Novagen) yielding N-terminally
hexahistidine-tagged SUMO fusion proteins (FimXDEAL and FimXEAL). The
hexahistidine tag and the hexahistidine-tagged SUMO moiety were cleavable
by using Prescission protease or the protease Ulp-1 from S. cerevisiae,
respectively. Proteins were produced following standard liquid chromatog-
raphy techniques as described previously (De et al., 2008). A detailed protocol
is provided in Supplemental Data.
Crystallization, X-Ray Data Collection, and Structure Solution
All crystals were obtained by hanging drop vapor diffusion by mixing equal
volumes of protein (5–30 mg/ml) and reservoir solution followed by incubation
at 20C. For FimXEAL and FimXEALdc-di-GMP the reservoir solution comprised
0.1 M HEPES (pH 7.1), 1.1 M ammonium sulfate, 0.5% PEG8000. Cyclic
di-GMP bound crystals were obtained by soaking nucleotide-free crystals in
reservoir solution supplemented with 1 mM c-di-GMP. Crystals of FimXGGDEF
were obtained by incubation over a reservoir solution comprising 0.1 M BisTris
(pH 6.5), 29%–33% Peg MME 5000. Crystals of FimXdual were obtained by incu-
bation over a reservoir solution comprising 0.1 M NaOAc (pH 5.0), 0.5–0.9 M Na-
formate, and 5 mM GTP/MgCl2. For cryoprotection, single crystals were soaked
in reservoir solution supplemented with 10% xylitol or 20% glycerol. All crystals
were flash-frozen in liquid nitrogen and kept at 100K during data collection.
Data sets were collected using synchrotron radiation at the Cornell High
Energy Synchrotron Source (CHESS, Ithaca, beamlines A1 and F1) and at
the National Synchrotron Light Source (NSLS, Brookhaven, beamline X29A).
Data reduction was carried out with the software XDS (Kabsch, 1993). Struc-
tures were solved by molecular replacement or single anomalous dispersion
using the software package Phenix (Adams et al., 2002). The models were built
and refined manually using Coot (Emsley and Cowtan, 2004), followed by iter-
ative minimization cycles in Phenix (Adams et al., 2002). Crystallographic
statistics for data collections and refinements are shown in Table 1.
Structures were analyzed by using the protein interfaces, surfaces and
assemblies service PISA at European Bioinformatics Institute (http://www.
ebi.ac.uk/msd-srv/prot_int/pistart.html) (Krissinel and Henrick, 2007). Struc-
ture superimpositions were performed with LSQMAN (Kleywegt, 1996) and
illustrations were made in Pymol (DeLano Scientific).
Nucleotide Loading State and Phosphodiesterase Assays
Reverse-phase high-performance liquid chromatography was used to sepa-
rate nucleotides as described previously (De et al., 2008). A detailed protocol
is provided in Supplemental Data.All rights reserved
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Structure of the c-di-GMP Receptor FimXIsothermal Titration Calorimetry
Apparent dissociation constants (Kd) and stoichiometry of interactions were
measured by isothermal titration calorimetry (ITC) using a VP calorimeter
(Microcal, Amherst, MA). Calorimetric titrations of c-di-GMP (250 mM in the
syringe; 10 ml injections) and FimX (25 mM in the cuvette) were carried out at
20C in assay buffer (25 mM Tris-Cl [pH 8.5], 100 mM NaCl) with a spacing
of 300 s between injections. ITC data were analyzed by integrating heat effects
normalized to the amount of injected protein and curve-fitting based on
a single-site binding model using the Origin software package (Microcal,
Northampton, MA). The dissociation constant was derived from the data by
using standard procedures.
Analytical Ultracentrifugation
Sedimentation velocity experiments were carried out using an XL-I analytical
ultracentrifuge (Beckman Coulter) equipped with an AN-50 Ti rotor. Proteins
(0.5–2 mg/ml) were diluted in assay buffer and were analyzed at a centrifuga-
tion speed of 110,0003 g. Data collection was carried out at 280 nm, followed
by data analysis using the program SedFit (version 11.0).
Small Angle X-ray Scattering (SAXS) and SAXS-Based Shape
Reconstruction
SAXS data were collected at the Cornell High Energy Synchrotron Source
(CHESS, Ithaca, beamline G1) at an electron energy of 8 KeV or at the
Advanced Photon Source (APS, BESSRC-CAT, beamline 12-IDC, Argonne,
IL) at the electron energy of 12 KeV. Data were collected at 4C on homoge-
neous samples. Data reduction, analysis, and free-atom modeling of the
SAXS data were carried out by using the program package ATSAS (Petoukhov
et al., 2007). A detailed description is provided in Supplemental Data.
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